Literature DB >> 21744169

Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arrays.

Ludwig G Strauss1, Dirk Koczan, Marcel Seiz, Jochen Tuettenberg, Kirsten Schmieder, Leyun Pan, Caixia Cheng, Antonia Dimitrakopoulou-Strauss.   

Abstract

PURPOSE: The kinetics of Ga-68-BZH3, a Ga-68-bombesin analog, was compared to molecular biological data obtained from gene arrays in seven patients with a recurrent glioma. The primary aim of this study was the correlation of receptor expression and tracer kinetics. PROCEDURES: Dynamic positron emission tomography studies were performed and the data were analyzed by a volume-of-interest technique using a two-tissue compartment model as well as a non-compartment model. Gene array data were obtained from gene array analysis of tumor tissue samples.
RESULTS: The correlation analysis revealed a significant nonlinear correlation of r = 0.89 (p < 0.03) for k1 and BB(2) (gastrin-releasing peptide receptor). BB(1) and BB(3) were not significantly correlated with k1. vb and k3 were not significantly correlated with the expression data of the receptors on the p < 0.05 level.
CONCLUSIONS: The parameter k1 is correlated with the expression of BB(2) based on gene array data. The quantitative analysis of the Ga-68-BZH3 kinetics can be used to predict the receptor expression of BB(2) in gliomas based on k1 of the compartment analysis. However, this study is limited to the expression data on the mRNA level and further studies are needed to assess the correlation of gene expression on the protein level.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21744169     DOI: 10.1007/s11307-011-0508-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  26 in total

Review 1.  Genomics, gene expression and DNA arrays.

Authors:  D J Lockhart; E A Winzeler
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

2.  99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes.

Authors:  Francesco Scopinaro; Giuseppe De Vincentis; Alexandra D Varvarigou; Cesare Laurenti; Francesco Iori; Silvia Remediani; Stella Chiarini; Salvatore Stella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-21       Impact factor: 9.236

3.  Fusion of positron emission tomography (PET) and gene array data: a new approach for the correlative analysis of molecular biological and clinical data.

Authors:  Ludwig G Strauss; Leyun Pan; Dirk Koczan; Sven Klippel; Krzysztof Mikolajczyk; Cyrill Burger; Uwe Haberkorn; Klaus Schönleben; Hans-Jürgen Thiesen; Antonia Dimitrakopoulou-Strauss
Journal:  IEEE Trans Med Imaging       Date:  2007-06       Impact factor: 10.048

4.  The role of 18F-FLT in cancer imaging: does it really reflect proliferation?

Authors:  Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

5.  Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.

Authors:  Antonia Dimitrakopoulou-Strauss; Marcel Seiz; Jochen Tuettenberg; Kirsten Schmieder; Michael Eisenhut; Uwe Haberkorn; Ludwig G Strauss
Journal:  Clin Nucl Med       Date:  2011-02       Impact factor: 7.794

6.  Bombesin induces angiogenesis and neuroblastoma growth.

Authors:  Junghee Kang; Titilope A Ishola; Naira Baregamian; Joshua M Mourot; Piotr G Rychahou; B Mark Evers; Dai H Chung
Journal:  Cancer Lett       Date:  2007-03-26       Impact factor: 8.679

7.  Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas.

Authors:  Marcel Seiz; Antonia Dimitrakopoulou-Strauss; Gerrit A Schubert; Carolin Weinmann; Ludwig G Strauss; Michael Eisenhut; Jochen Tuettenberg
Journal:  Hell J Nucl Med       Date:  2008 Sep-Dec       Impact factor: 1.102

8.  Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models.

Authors:  Marianne Schrader de Oliveira; Giovana Cechim; Elisandra Braganhol; Daniel Garcia Santos; Luise Meurer; Cláudio Galvão de Castro; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Gilberto Schwarstmann; Ana Maria Oliveira Battastini; Guido Lenz; Rafael Roesler
Journal:  J Neurooncol       Date:  2009-01-08       Impact factor: 4.130

9.  Correlating gene and protein expression data using Correlated Factor Analysis.

Authors:  Chuen Seng Tan; Agus Salim; Alexander Ploner; Janne Lehtiö; Kee Seng Chia; Yudi Pawitan
Journal:  BMC Bioinformatics       Date:  2009-09-01       Impact factor: 3.169

10.  Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate.

Authors:  Laura E Pascal; Lawrence D True; David S Campbell; Eric W Deutsch; Michael Risk; Ilsa M Coleman; Lillian J Eichner; Peter S Nelson; Alvin Y Liu
Journal:  BMC Genomics       Date:  2008-05-23       Impact factor: 3.969

View more
  7 in total

Review 1.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

Review 2.  Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging.

Authors:  Kenneth M Tichauer; Yu Wang; Brian W Pogue; Jonathan T C Liu
Journal:  Phys Med Biol       Date:  2015-07-02       Impact factor: 3.609

3.  68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.

Authors:  Jingjing Zhang; Deling Li; Lixin Lang; Zhaohui Zhu; Ling Wang; Peilin Wu; Gang Niu; Fang Li; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-10-08       Impact factor: 10.057

Review 4.  Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma.

Authors:  Aurélie Moreau; Olivia Febvey; Thomas Mognetti; Didier Frappaz; David Kryza
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244

5.  Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist.

Authors:  Michael Hofstetter; Euy Sung Moon; Fabio D'Angelo; Lucien Geissbühler; Ian Alberts; Ali Afshar-Oromieh; Frank Rösch; Axel Rominger; Eleni Gourni
Journal:  EJNMMI Radiopharm Chem       Date:  2020-11-30

Review 6.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

Review 7.  Radiolabeled PSMA Inhibitors.

Authors:  Oliver C Neels; Klaus Kopka; Christos Liolios; Ali Afshar-Oromieh
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.